← Evidence map

ReviewNPJ breast cancer2026

Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.

Kenan Aloss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42140928